4.53
0.02 (0.44%)
0.02 (0.44%)
Upgrade to Real-Time
Regular Market
Low
3.15
High
9.00
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.02 | 0.44% | 4.53 | 13:51:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.45 | 4.45 | 4.70 | 4.51 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.52 | 4.53 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,128 | 390,362 | $ 4.54 | $ 1,771,347 | - | 3.15 - 9.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:51:19 | 100 | $ 4.53 | USD |
Period:
Draw Mode:
Zynerba Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 186.87M | 41.25M | 39.99M | $ - | $ - | -1.93 | -2.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 5.90% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.3692 | 4.845 | 4.35 | 4.63 | 459,660 | 0.1608 | 3.68% |
| 1 Month | 6.00 | 6.07 | 4.35 | 5.08 | 612,520 | -1.47 | -24.5% |
| 3 Months | 4.39 | 6.07 | 3.91 | 5.02 | 1,303,808 | 0.14 | 3.19% |
| 6 Months | 3.59 | 9.00 | 3.40 | 5.29 | 3,364,093 | 0.94 | 26.18% |
| 1 Year | 3.89 | 9.00 | 3.15 | 4.99 | 2,034,405 | 0.64 | 16.45% |
| 3 Years | 7.72 | 16.47 | 2.55 | 6.50 | 1,404,700 | -3.19 | -41.32% |
| 5 Years | 7.17 | 25.95 | 2.55 | 7.59 | 1,024,396 | -2.64 | -36.82% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |
